Pharmacoeconomics is the application of economic techniques to the evaluation of new pharmaceutical products. Based upon theories and practices developed within the sub-discipline of health economics, pharmacoeconomics employs the methods of economic evaluation to assess the relative costs and benefits of novel interventions. Given the seemingly high prices of many new medicines, the approach is widely used in countries where value for money in healthcare purchasing is a major concern. The importance of this form of appraisal is signified by the existence of a specialist journal dedicated to the field, PharmacoEconomics, and the large membership of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR).
I have been teaching health economics and pharmacoeconomics since the mid-1990s. In 1998, I became the founding course director of the MSc in health economics at Birmingham University, UK. Since that time, I have taught health- and pharmaco- economics to students and healthcare professional in both academic and healthcare settings. As a philosophy, I believe that the principles of economics should be made accessible and understandable to people outside of the discipline. Therefore, my lectures and seminar are designed to explain difficult economic concepts simply. In twenty years of teaching, I have consistently received excellent feedback for my delivery and contents. In 2016, I began teaching a new module in pharmacoeconomics for the MSc in Pharmacology and Drug Discovery . During the first tranche, formal student feedback was 100 per cent positive. This module is also offered externally to students and professionals outside Coventry, as part of our summer school programme.
In March 2016, I was awarded funds from the Newton-Mosharafa fund run the British Council Coventry University Pharmacoeconomics Programme (BCCUPP). The aim of this development programme is to provide skills and training in pharmacoeconomics for academics and pharmacists in Egypt. The objectives are: (i) in partnership, to develop and to pilot a training programme that advances the understanding of pharmacoeconomics within Egypt, (ii) to enhance the understanding and the quality of research in Egypt related to the economic evaluations of pharmaceuticals, and (iii) to develop research that provides insights into the efficient use of healthcare resources in Egypt. As part of the programme, knowledge transfer will occur during a 5 day workshop, provided in the UK for delegates from Egyptian universities or hospitals. The workshop will be run twice, for two separate cohorts of 10 pharmacists. The first workshop will be held in London and Coventry on 25 to 29 July 2016 (inclusive). This will be based upon five full days teaching in pharmacoeconomics, including an educational visit to the R&D facilities of GSK. The second workshop will be held in summer 2017. As well as teaching, I was recently a co-author with Dr Dalia Dawoud on a chapter entitled “Economic evaluation and its types”, which was published in Babar Z. (2016). Economic Evaluation of Pharmacy Services. Academic Press.